Tag
Craif
- Craif raises US$33M to get its urine cancer test into American clinics
- BioMark expands lung cancer screening portfolio with patented urine test
- BeOne Medicines gets positive stock bump on RBC Capital upgrade
- Guardant Health gets Breakthrough Device Designation from FDA for cancer detection test
- Japanese startup 'Craif' raises US$22M to bring urine cancer biopsy to the U.S.